OpenAI experienced a significant leadership shake-up on April 17, 2026, when three senior executives departed in a single day and the company shut down its publicly championed science division. The departures included Kevin Weil, the former chief product officer turned science initiative leader; Srinivas Narayanan, the chief technology officer for enterprise applications; and Bill Peebles, who headed the Sora video-generation product. The moves underscore mounting pressure on Sam Altman's company to streamline operations as it prepares for a reported initial public offering later in 2026 .

What Happened to OpenAI for Science?

OpenAI for Science was one of the company's most visible bets on applying frontier artificial intelligence to hard scientific problems. Launched with significant fanfare, the initiative attracted world-class academics and positioned itself as a bridge between cutting-edge AI models and real-world research challenges in physics, biology, and chemistry .

Kevin Weil joined OpenAI as chief product officer in June 2024, bringing product experience from Instagram and Twitter. By September 2025, he had transitioned internally to lead the science initiative. In January 2026, the team launched Prism, a dedicated web application designed to give researchers a tailored AI workspace. The timing seemed promising. That same month, MIT Technology Review profiled the initiative as active and ambitious, highlighting GPT-5.2's performance on the GPQA graduate-level science benchmark, where it scored 92 percent compared to GPT-4's 39 percent, a striking leap in capability .

"Today is my last day at OpenAI, as OpenAI for Science is being decentralized into other research teams. It's been a mind-expanding two years, from Chief Product Officer to joining the research team and starting OpenAI for Science," said Kevin Weil.

Kevin Weil, former Chief Product Officer and Science Initiative Lead at OpenAI

Three months after the MIT profile, the division no longer exists. Prism has been sunset, and the roughly ten-person team that built and ran it has been folded into Codex, OpenAI's AI coding application, under Codex head Thibault Sottiaux. An OpenAI spokesperson described the changes as part of a broader effort to unify the company's business and product strategy. In the same announcement, OpenAI introduced GPT-Rosalind, a new series of models designed specifically for life sciences researchers .

Why Is OpenAI Consolidating Its Product Portfolio?

The dissolution of OpenAI for Science is not an isolated decision. It reflects a strategic pivot that has been building since at least March 2026, when Fidji Simo, OpenAI's chief executive of AGI (artificial general intelligence) deployment, told staff the company needed to simplify its product offerings. The pattern is becoming unmistakable: specialized applications are being discontinued or absorbed into a single platform .

OpenAI has broader ambitions to turn Codex, its AI coding application, into an "everything app" that consolidates multiple capabilities into one product surface. Rather than maintaining a portfolio of specialized tools for different domains, the company is consolidating its agentic ambitions, meaning AI systems capable of taking independent actions, into a single product interface. The fate of Sora and Prism demonstrates that specialized applications at OpenAI carry a short shelf life when immediate commercial viability is not apparent .

• Sora Video Generation: The video-generation application has already been discontinued as part of the broader consolidation strategy.
• Prism Web Application: The dedicated AI workspace for researchers has been sunset, with its team absorbed into Codex.
• Codex Integration: The AI coding application is expanding to absorb capabilities from deprecated products and becoming the primary product interface.

How Is OpenAI's Leadership Instability Affecting the Company?

Friday's triple exit does not exist in a vacuum. The scale of OpenAI's executive turnover over the past eighteen months is unusual for a company of its standing. Mira Murati, OpenAI's chief technology officer, departed in 2024. Greg Brockman, the company's co-founder and president, has been drawn back into an active role overseeing products after Fidji Simo took medical leave. Chief marketing officer Kate Rouch also stepped away for health reasons. Chief operating officer Brad Lightcap moved into a loosely defined "special projects" role. Now, in a single day, a former chief product officer, a chief technology officer for enterprise, and a product head are gone .

For those who build products and integrations on top of OpenAI's infrastructure, this consolidation event carries real consequences. The Codex ecosystem is about to become larger and more complex, absorbing capabilities from Prism and potentially other deprecated products. The API (application programming interface) surface, which developers rely on to integrate OpenAI's tools into their own applications, is shifting. The leadership instability, now touching product, enterprise, video, science, operations, and marketing, raises legitimate questions about the continuity of roadmaps and long-term strategic direction .

What's Driving the Consolidation Ahead of OpenAI's IPO?

OpenAI raised $6.6 billion at a $157 billion valuation in October 2024 and reported 300 million weekly active ChatGPT users at that time. The competitive landscape it now faces, however, is meaningfully different from the one it dominated just two years ago. Anthropic, OpenAI's closest peer in the frontier model race, has seen its revenue reportedly grow ninefold year on year. Google DeepMind continues to hold significant credibility in scientific AI applications, anchored by the influence of AlphaFold, a system that predicts protein structures .

As OpenAI reportedly targets an IPO later in 2026, the pressure to present a coherent, simplified product narrative to prospective public market investors is considerable. Wall Street investors typically prefer companies with clear, unified product strategies over those with fragmented portfolios. The consolidation into Codex as an "everything app" may be designed to create a simpler story for investors: one powerful platform rather than multiple specialized tools competing for resources and attention .

The departures and restructuring signal that OpenAI is willing to sacrifice near-term scientific ambitions for near-term financial clarity. Whether this trade-off positions the company for long-term success in the competitive AI landscape remains an open question for investors and industry observers alike.

" }